Imaging for Detection of Ischemic Injury in a Porcine Ex-Vivo Lung Perfusion System Prior to Transplantation. Acad Radiol. 2019 Feb;26(2):170-178. doi: 10.1016/j.acra.2018.05.006. Epub 2018 Jun 19. PMID:
Schmitt, Nephrology, OE 6840; project: Autophagy in accelerated aging and senescence of Renal Transplantation Final exam June 2015. Sebastian Brennig GERMANY supervisor: Prof. Dr. Moritz, REBIRTH, OE 8882
on of mesenchymal stem cells: impact on blood vessel repair after vascular injury and organ transplantation Final exam June 2012 Tamaryin Godinho PORTUGAL supervisor: Prof. Dr. Baum, Experimental Hematology
ESPN CKD-MBD working group. Nephrol Dial Transplant. 2021; 36:442-451. hier CKD-MBD post kidney transplantation. Haffner D and Leifheit-Nestler M. Pediatr Nephrol . 2021; 36:41-50. hier 2020 Bone and Mineral [...] Endocrinol (Lausanne). 2018; 9:278. hier Impaired microcirculation in children after kidney transplantation: Everolimus versus myophenolate based immunosuppression regimen. Ruben S, Kreuzer M, Büscher
Salman, J., Natanov, R. , et al. (2022). Cell-Free Hemoglobin in Acute Kidney Injury after Lung Transplantation and Experimental Renal Ischemia/Reperfusion. Int J Mol Sci 23 . Hage, A., de Vries, M., Leffler
with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol. 2014 Apr;34(3):331-9.
Project: Molecular risk-stratification for individualized immunosuppression in patients after liver transplantation using rejection-associated transcripts Giuseppe Cipriano ITALY; Cipriani.Giuseppe @ mh-hannover
Oldhafer KJ, Weimann A, Schlitt HJ, Scheumann GFW, Flemming P, Ringe B, Pichlmayr R: Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997; 225(4): 347-54 Petersen C, Biermanns D,
purification of clinical grade T cells for personalized antiviral T-cell immunotherapy after transplantation. Final exam November 2020. Jovana Markovic SERBIA Supervisor: Dr. Amar Deep Sharma, AG Cantz
stungen basieren auf den drei etablierten Forschungsschwerpunkten „Infektion & Immunität“, „Transplantation & Regeneration“ und „Biomedizintechnik & Implantate“ sowie dem neuen Potentialbereich „Onkologie“